<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Status of Research Tool Patents Still in Limbo</title>
	<atom:link href="http://www.patentbaristas.com/archives/2007/08/02/status-of-research-tool-patents-still-in-limbo/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patentbaristas.com/archives/2007/08/02/status-of-research-tool-patents-still-in-limbo/</link>
	<description>Freshly Brewed Bio/Pharma Chat. Served Up Daily.</description>
	<lastBuildDate>Thu, 18 Mar 2010 11:54:35 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Patent Baristas &#187; Is the Use of a Patented Formulation or Delivery Technology Safe under the FDA Research Exemption &#8220;Safe Harbor&#8221;?</title>
		<link>http://www.patentbaristas.com/archives/2007/08/02/status-of-research-tool-patents-still-in-limbo/comment-page-1/#comment-37638</link>
		<dc:creator>Patent Baristas &#187; Is the Use of a Patented Formulation or Delivery Technology Safe under the FDA Research Exemption &#8220;Safe Harbor&#8221;?</dc:creator>
		<pubDate>Fri, 18 Jan 2008 21:44:22 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2007/08/02/status-of-research-tool-patents-still-in-limbo/#comment-37638</guid>
		<description>[...] a follow-up on our earlier discussion regarding the Supreme Court&#8217;s broad scope of the research exemption to the Integra case, the question came up asking if a patented delivery formulation &#8212; say, a sustained release [...]</description>
		<content:encoded><![CDATA[<p>[...] a follow-up on our earlier discussion regarding the Supreme Court&#8217;s broad scope of the research exemption to the Integra case, the question came up asking if a patented delivery formulation &#8212; say, a sustained release [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
